Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.
paper
Cited
Public
Unavailable
- Authors
- Kreek, Mary Jeanne; Bart, Gavin; Lilly, Charles; LaForge, K Steven; Nielsen, David A
- Year
- 2005
- Journal
- Pharmacological reviews
- PMID
- 15734726
- DOI
- 10.1124/pr.57.1.1
Opiate and cocaine addictions are major social and medical problems that impose a significant burden on society. Despite the size and scope of these problems, there are few effective treatments for these addictions. Methadone maintenance is an effective and most widely used treatment for opiate addiction, allowing normalization of many physiological abnormalities caused by chronic use of short-acting opiates. There are no pharmacological treatments for cocaine addiction. Epidemiological, linkage, and association studies have demonstrated a significant contribution of genetic factors to the addictive diseases. This article reviews the molecular genetics and pharmacogenetics of opiate and cocaine addictions, focusing primarily on genes of the opioid and monoaminergic systems that have been associated with or have evidence for linkage to opiate or cocaine addiction. This evidence has been marshalled either through identification of variant alleles that lead to functional alterations of gene products, altered gene expression, or findings of linkage or association studies. Studies of polymorphisms in the mu opioid receptor gene, which encodes the receptor target of some endogenous opioids, heroin, morphine, and synthetic opioids, have contributed substantially to knowledge of genetic influences on opiate and cocaine addiction. Other genes of the endogenous opioid and monoaminergic systems, particularly genes encoding dopamine beta-hydroxylase, and the dopamine, serotonin, and norepinephrine transporters have also been implicated. Variants in genes encoding proteins involved in metabolism or biotransformation of drugs of abuse and also of treatment agents are reviewed.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| <i>Kappa</i>-opioid receptor gene (<i>OPRK1</i>) variations associated with opioid abstinence behaviors among chronic heroin users. | Greenwald MK et al. | β | 2025 | β |
| The "amount" criterion in the determination of personal possession offenses involving the four most common drugs in TΓΌrkiye's supreme court. | Arslan Z et al. | β | 2025 | β |
| Association of KRAS and TERT Genetic Variants with Opioid Dependence in a Large Clinical Cohort | Cuomo RE | β | 2024 | β |
| Brain microRNA profiles after exposure to heroin in rats. | Pence HH et al. | β | 2024 | β |
| Comparison of the Effects of OPRM1 A118G Polymorphism Using Different Opioids: A Prospective Study. | Takemura M et al. | β | 2024 | β |
| Substance use disorders and cooperative research on addictions: Spanish approach as a model. | CΓ‘rdenas-Quesada J et al. | β | 2024 | β |
| [Bronchial diseases and heroin use. A systematic review]. | Underner M et al. | β | 2023 | β |
| Endocannabinoid-dependent decrease of GABAergic transmission on dopaminergic neurons is associated with susceptibility to cocaine stimulant effects in pre-adolescent male MAOA hypomorphic mice exposed to early life stress. | Serra V et al. | β | 2023 | β |
| The Influence of Mediators on the Relationship Between Antenatal Opioid Agonist Exposure and the Severity of Neonatal Opioid Withdrawal Syndrome. | Devlin LA et al. | β | 2023 | β |
| Knock-In Mouse Models to Investigate the Functions of Opioid Receptors <i>in vivo</i>. | Degrandmaison J et al. | β | 2022 | β |
| Pharmacogenetics of Addiction Therapy. | Graham DP et al. | β | 2022 | β |
| Cerebral vasculitis associated with drug abuse. | Younger DS | β | 2021 | β |
| Pharmacogenomics and prescription opioid use. | Benjeddou M et al. | β | 2021 | β |
| Pharmacokinetic and pharmacodynamic analyses of cocaine and its metabolites in behaviorally divergent inbred mouse strains. | Zhu J et al. | β | 2021 | β |
| Spinocerebellar ataxia type 23 (SCA23): a review. | Wu F et al. | β | 2021 | β |
| The OPRD1 rs678849 variant influences outcome of disulfiram treatment for cocaine dependency in methadone-maintained patients. | Thomas PS et al. | β | 2021 | β |
| A Randomized Controlled Comparison of Epidural Analgesia Onset Time and Adverse Reactions During Labor With Different Dose Combinations of Bupivacaine and Sufentanil. | Wang T et al. | β | 2020 | β |
| Association between three common genetic polymorphisms of XPC and susceptibility to heroin dependency. | Qasemian-Talgard A et al. | β | 2020 | β |
| Gene Variants in Hepatic Metabolism, Gamma-Aminobutyric Acid-ergic Reward, and Prostaglandin Pathways in Opioid-Consuming and Opioid-NaΓ―ve Patients Presenting for Lower Extremity Total Joint Replacement. | Odell DW et al. | β | 2020 | β |
| Non-pharmacological factors that determine drug use and addiction. | Ahmed SH et al. | β | 2020 | β |
| Opioid and neuroHIV Comorbidity - Current and Future Perspectives. | Fitting S et al. | β | 2020 | β |
| Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism. | Cornett EM et al. | β | 2020 | β |
| Precision therapeutic opioid dosing implications from genetic biomarkers and craving score. | Chang HW et al. | β | 2020 | β |
| Salivary Cortisol Levels Are Associated with Craving and Cognitive Performance in Cocaine-Abstinent Subjects: A Pilot Study. | Sampedro-Piquero P et al. | β | 2020 | β |
| The Streetlight Effect: Reappraising the Study of Addiction in Light of the Findings of Genome-wide Association Studies. | Hall FS et al. | β | 2020 | β |
| A Genetic Model of Impulsivity, Vulnerability to Drug Abuse and Schizophrenia-Relevant Symptoms With Translational Potential: The Roman High- vs. Low-Avoidance Rats. | Giorgi O et al. | β | 2019 | β |
| A novel neurobehavioral framework of the effects of positive early postnatal experience on incentive and consummatory reward sensitivity. | Fu Y et al. | β | 2019 | β |
| Association of variants of prodynorphin promoter 68-bp repeats in caucasians with opioid dependence diagnosis: Effect on age trajectory of heroin use. | Yuferov V et al. | β | 2019 | β |
| Central Nervous System Vasculitis Due to Substance Abuse. | Younger DS | β | 2019 | β |
| Coevolution of Residues Provides Evidence of a Functional Heterodimer of 5-HT<sub>2A</sub>R and 5-HT<sub>2C</sub>R Involving Both Intracellular and Extracellular Domains. | Fongang B et al. | β | 2019 | β |
| DRD2 and ANKK1 genes associate with late-onset heroin dependence in men. | Tsou CC et al. | β | 2019 | β |
| <i>OPRM1</i> A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches. | Taqi MM et al. | β | 2019 | β |
| Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders. | Burns JA et al. | β | 2019 | β |
| Polydrug use patterns and their impact on relapse among heroin-dependent patients in Shanghai, China. | Chen T et al. | β | 2019 | β |
| VMAT2 gene (<i>SLC18A2</i>) variants associated with a greater risk for developing opioid dependence. | Randesi M et al. | β | 2019 | β |
| Enkephalin as a Pivotal Player in Neuroadaptations Related to Psychostimulant Addiction. | Mongi-Bragato B et al. | β | 2018 | β |
| Neurobiology of Opioid Use Disorder and Comorbid Traumatic Brain Injury. | Kosten TR et al. | β | 2018 | β |
| Opioid Exposure is Associated with Aberrant DNA Methylation of OPRM1 Promoter Region in a Chinese Han Population. | Xu J et al. | β | 2018 | β |
| Opioid Receptors Gene Polymorphism and Heroin Dependence in Iran. | Soleimani Asl S et al. | β | 2018 | β |
| Oprm1 A112G, a single nucleotide polymorphism, alters expression of stress-responsive genes in multiple brain regions in male and female mice. | Collins D et al. | β | 2018 | β |
| The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review. | Oueslati B et al. | β | 2018 | β |
| Association of maternal and infant variants in PNOC and COMT genes with neonatal abstinence syndrome severity. | Wachman EM et al. | β | 2017 | β |
| [Asthma and heroin use]. | Underner M et al. | β | 2017 | β |
| Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder. | Hirasawa-Fujita M et al. | β | 2017 | β |
| Onset of labour epidural analgesia with low-dose bupivacaine and different doses of fentanyl. | Vedagiri Sai R et al. | β | 2017 | β |
| Pharmacoepigenomics of opiates and methadone maintenance treatment: current data and perspectives. | Marie-Claire C et al. | β | 2017 | β |
| Pharmacogenomics in Pain Management. | Saba R et al. | β | 2017 | β |
| A Population-Based Study of Four Genes Associated with Heroin Addiction in Han Chinese. | Li Y et al. | β | 2016 | β |
| Association between genetic variations of NMDA receptor NR3 subfamily genes and heroin addiction in male Han Chinese. | Xie X et al. | β | 2016 | β |
| Association between serotonin transporter gene polymorphisms and heroin dependence: a meta-analytic study. | Lin PY et al. | β | 2016 | β |
| Genome-Wide Association of Heroin Dependence in Han Chinese. | Kalsi G et al. | β | 2016 | β |
| H4K5 histone acetylation of <i>BRG1</i> is associated with heroin administration rather than addiction. | Xu L et al. | β | 2016 | β |
| Integrative Bayesian analysis of neuroimaging-genetic data with application to cocaine dependence. | Azadeh S et al. | β | 2016 | β |
| Off-Target drug effects resulting in altered gene expression events with epigenetic and "Quasi-Epigenetic" origins. | Anderson SJ et al. | β | 2016 | β |
| Relationship among methadone dose, polymorphisms of dopamine D2 receptor and tri-dimensional personality questionnaire in heroin-addicted patients. | Huang MW et al. | β | 2016 | β |
| Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence. | Randesi M et al. | β | 2016 | β |
| Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system. | Patriquin MA et al. | β | 2015 | β |
| An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research. | Norman LR et al. | β | 2015 | β |
| Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human ΞΌ-opioid receptor (OPRM1). | Knapman A et al. | β | 2015 | β |
| Effect of Different Psychoactive Substances on Serum Biochemical Parameters. | Sanli DB et al. | β | 2015 | β |
| Event-related potentials in performance monitoring are influenced by the endogenous opioid system. | Pfabigan DM et al. | β | 2015 | β |
| Genotyping test with clinical factors: better management of acute postoperative pain? | Hajj A et al. | β | 2015 | β |
| Gray matter abnormalities associated with betel quid dependence: a voxel-based morphometry study. | Chen F et al. | β | 2015 | β |
| Low-dose add-on memantine treatment may improve cognitive performance and self-reported health conditions in opioid-dependent patients undergoing methadone-maintenance-therapy. | Chang YH et al. | β | 2015 | β |
| Mouse model of the OPRM1 (A118G) polymorphism: differential heroin self-administration behavior compared with wild-type mice. | Zhang Y et al. | β | 2015 | β |
| Possible mechanism for inhibition of morphine formation from 6-acetylmorphine after intake of street heroin. | Andersson M et al. | β | 2015 | β |
| Regional brain [(11)C]carfentanil binding following tobacco smoking. | Domino EF et al. | β | 2015 | β |
| The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: A systematic review. | Bauer IE et al. | β | 2015 | β |
| Variations in opioid receptor genes in neonatal abstinence syndrome. | Wachman EM et al. | β | 2015 | β |
| A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the ΞΌ opioid receptor gene OPRM1 via hnRNPH interactions. | Xu J et al. | β | 2014 | β |
| Alcohol: a stimulant activating brain stress responsive systems with persistent neuroadaptation. | Zhou Y et al. | β | 2014 | β |
| Brain region- and sex-specific alterations in DAMGO-stimulated [(35) S]GTPΞ³S binding in mice with Oprm1 A112G. | Wang YJ et al. | β | 2014 | β |
| Characterization of serotonin transporter gene (SLC6A4) polymorphisms and its association with drug dependence in a Jordanian Arab population. | Al-Eitan LN et al. | β | 2014 | β |
| Comparative gene expression profiling analysis of lymphoblastoid cells reveals neuron-specific enolase gene (ENO2) as a susceptibility gene of heroin dependence. | Liao DL et al. | β | 2014 | β |
| Drugs currently in Phase II clinical trials for cocaine addiction. | Kim JH et al. | β | 2014 | β |
| Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome. | Wachman EM et al. | β | 2014 | β |
| Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors. | Hauser KF et al. | β | 2014 | β |
| Pharmacogenetics of addiction therapy. | Nielsen DA et al. | β | 2014 | β |
| The Genetics, Neurogenetics and Pharmacogenetics of Addiction. | Demers CH et al. | β | 2014 | β |
| Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: A comprehensive review of the literature. | Ruiz-ColΓ³n K et al. | β | 2014 | β |
| Advances in genetic studies of substance abuse in China. | Sun Y et al. | β | 2013 | β |
| Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction. | Levran O et al. | β | 2013 | β |
| Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study. | Beer B et al. | β | 2013 | β |
| Case-control association analysis of polymorphisms in the Ξ΄-opioid receptor, OPRD1, with cocaine and opioid addicted populations. | Crist RC et al. | β | 2013 | β |
| Caudate Volume in Offspring at Ultra High Risk for Alcohol Dependence: COMT Val158Met, DRD2, Externalizing Disorders, and Working Memory. | Hill SY et al. | β | 2013 | β |
| Estimation of BDNF gene polymorphism and predisposition to dependence development for selected psychoactive compounds: genetic aspects of addiction with the selected drugs, amphetamine, tetrahydrocannabinol and opiates. | Biskupska J et al. | β | 2013 | β |
| Genetic analysis of AUTS2 as a susceptibility gene of heroin dependence. | Chen YH et al. | β | 2013 | β |
| Genetic variants associated with addictive behavior in Colombian addicted and non-addicted to heroin or cocaine. | Isaza C et al. | β | 2013 | β |
| Implications of genome wide association studies for addiction: are our a priori assumptions all wrong? | Hall FS et al. | β | 2013 | β |
| Mu opioids and their receptors: evolution of a concept. | Pasternak GW et al. | β | 2013 | β |
| NCK2 is significantly associated with opiates addiction in African-origin men. | Liu Z et al. | β | 2013 | β |
| OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis. | Haerian BS et al. | β | 2013 | β |
| Pharmacogenetics of opiates in clinical practice: the visible tip of the iceberg. | Hajj A et al. | β | 2013 | β |
| Positive association between--1021TT genotype of dopamine beta hydroxylase gene and progressive behavior of injection heroin users. | Xie X et al. | β | 2013 | β |
| Shared and unique genetic contributions to attention deficit/hyperactivity disorder and substance use disorders: a pilot study of six candidate genes. | Carpentier PJ et al. | β | 2013 | β |
| The 2-methoxy methyl analogue of salvinorin A attenuates cocaine-induced drug seeking and sucrose reinforcements in rats. | Morani AS et al. | β | 2013 | β |
| Tolerance and sensitization to chronic escalating dose heroin following extended withdrawal in Fischer rats: possible role of mu-opioid receptors. | Seip-Cammack KM et al. | β | 2013 | β |
| Use of codeine-containing medicines by Irish psychiatric inpatients before and after regulatory limitations on their supply. | Agyapong VIO et al. | β | 2013 | β |
| A C17T polymorphism in the mu opiate receptor is associated with quantitative measures of drug use in African American women. | Crystal HA et al. | β | 2012 | β |
| A common single nucleotide polymorphism A118G of theΒ ΞΌ opioid receptor alters its N-glycosylation and protein stability. | Huang P et al. | β | 2012 | β |
| Association of polymorphisms of the mu opioid receptor gene with the severity of HIV infection and response to HIV treatment. | Proudnikov D et al. | β | 2012 | β |
| Association study of the Ξ²-arrestin 2 gene (ARRB2) with opioid and cocaine dependence in a European-American population. | Ambrose-Lanci LM et al. | β | 2012 | β |
| Behavioural genetics of the serotonin transporter. | Haddley K et al. | β | 2012 | β |
| Common and specific liability to addiction: approaches to association studies of opioid addiction. | Nielsen DA et al. | β | 2012 | β |
| Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent. | Al-Eitan LN et al. | β | 2012 | β |
| Design and self-assembly of a leucine-enkephalin analogue in different nanostructures: application of nanovesicles. | Koley P et al. | β | 2012 | β |
| Does food addiction exist? A phenomenological discussion based on the psychiatric classification of substance-related disorders and addiction. | Albayrak O et al. | β | 2012 | β |
| Epigenetics of drug abuse: predisposition or response. | Nielsen DA et al. | β | 2012 | β |
| Estimating ancestral proportions in a multi-ethnic US sample: implications for studies of admixed populations. | Levran O et al. | β | 2012 | β |
| Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction. | Clarke TK et al. | β | 2012 | β |
| Maintenance medication for opiate addiction: the foundation of recovery. | Bart G | β | 2012 | β |
| Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent. | Al-Eitan LN et al. | β | 2012 | β |
| Onset of labor epidural analgesia with ropivacaine and a varying dose of fentanyl: a randomized controlled trial. | Bang EC et al. | β | 2012 | β |
| Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics. | Kreek MJ et al. | β | 2012 | β |
| Reduced expression of the ΞΌ opioid receptor in some, but not all, brain regions in mice with OPRM1 A112G. | Wang YJ et al. | β | 2012 | β |
| The endogenous opioid system in cocaine addiction: what lessons have opioid peptide and receptor knockout mice taught us? | Yoo JH et al. | β | 2012 | β |
| The genetics of substance dependence. | Wang JC et al. | β | 2012 | β |
| The genetics of the opioid system and specific drug addictions. | Levran O et al. | β | 2012 | β |
| The MTHFR C677T Variant is Associated with Responsiveness to Disulfiram Treatment for Cocaine Dependency. | Spellicy CJ et al. | β | 2012 | β |
| Trait impulsivity and prefrontal gray matter reductions in cocaine dependent individuals. | Moreno-LΓ³pez L et al. | β | 2012 | β |
| Tridimensional personalities and polymorphism of dopamine D2 receptor among heroin addicts. | Teh LK et al. | β | 2012 | β |
| Utility of genetically modified mice for understanding the neurobiology of substance use disorders. | Fowler CD et al. | β | 2012 | β |
| ΞΊ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction. | Butelman ER et al. | β | 2012 | β |
| Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse. | Meyer MR et al. | β | 2011 | β |
| Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response. | Fonseca F et al. | β | 2011 | β |
| Haplotype block structure of the genomic region of the mu opioid receptor gene. | Levran O et al. | β | 2011 | β |
| Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients. | Hung CC et al. | β | 2011 | β |
| Meta-analysis and genome-wide interpretation of genetic susceptibility to drug addiction. | Li CY et al. | β | 2011 | β |
| Quantitative Detection of Β΅ Opioid Receptor: Western Blot Analyses Using Β΅ Opioid Receptor Knockout Mice. | Kasai S et al. | β | 2011 | β |
| Ξ²-Arrestin2 influences the response to methadone in opioid-dependent patients. | Oneda B et al. | β | 2011 | β |
| Could the inter-individual variability in cocaine-induced psychotic effects influence the development of cocaine addiction? Towards a new pharmacogenetic approach to addictions. | Brousse G et al. | β | 2010 | β |
| Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases. | Zhou Y et al. | β | 2010 | β |
| Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts. | Nielsen DA et al. | β | 2010 | β |
| Evidence for association of two variants of the nociceptin/orphanin FQ receptor gene OPRL1 with vulnerability to develop opiate addiction in Caucasians. | Briant JA et al. | β | 2010 | β |
| Introduction to Women, Children and Addiction. | Finnegan LP | β | 2010 | β |
| Khat use and neurobehavioral functions: suggestions for future studies. | Hoffman R et al. | β | 2010 | β |
| Long-term effects of chronic khat use: impaired inhibitory control. | Colzato LS et al. | β | 2010 | β |
| Mesocorticolimbic circuits are impaired in chronic cocaine users as demonstrated by resting-state functional connectivity. | Gu H et al. | β | 2010 | β |
| Mouse strain differences in locomotor, sensitisation and rewarding effect of heroin; association with alterations in MOP-r activation and dopamine transporter binding. | Bailey A et al. | β | 2010 | β |
| Neuropathic and chronic pain stimuli downregulate central mu-opioid and dopaminergic transmission. | Niikura K et al. | β | 2010 | β |
| New horizons for therapeutics in drug and alcohol abuse. | Jupp B et al. | β | 2010 | β |
| No influence of 5-HTTLPR gene polymorphism on migraine symptomatology, comorbid depression, and chronification. | Wieser T et al. | β | 2010 | β |
| Overview and historical perspective of four papers presented on research related to the endogenous opioid system. | Kreek MJ | β | 2010 | β |
| Pharmacogenetics of drug dependence: role of gene variations in susceptibility and treatment. | Khokhar JY et al. | β | 2010 | β |
| Pharmacotherapy in the treatment of addiction: methadone. | Kreek MJ et al. | β | 2010 | β |
| Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment. | Yuferov V et al. | β | 2010 | β |
| A functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain. | Yuferov V et al. | β | 2009 | β |
| Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty. | Mark TL et al. | β | 2009 | β |
| Association between ABCB1 C3435T polymorphism and increased risk of cannabis dependence. | Benyamina A et al. | β | 2009 | β |
| Association of IL-1B genetic polymorphisms with an increased risk of opioid and alcohol dependence. | Liu L et al. | β | 2009 | β |
| Bidirectional translational research: Progress in understanding addictive diseases. | Kreek MJ et al. | β | 2009 | β |
| Evaluation of heterogeneity in pharmacotherapy trials for drug dependence: a Bayesian approach. | Green CE et al. | β | 2009 | β |
| Genetic modulation of the pharmacological treatment of pain. | LΓΆtsch J et al. | β | 2009 | β |
| Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution. | Doehring A et al. | β | 2009 | β |
| Gnao1 (G alphaO protein) is a likely genetic contributor to variation in physical dependence on opioids in mice. | Kest B et al. | β | 2009 | β |
| Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts. | Nielsen DA et al. | β | 2009 | β |
| Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: A meta-analysis. | Coller JK et al. | β | 2009 | β |
| Opiate and cocaine addiction: from bench to clinic and back to the bench. | Kreek MJ et al. | β | 2009 | β |
| Opioid dependence as a chronic disease: the interrelationships between length of stay, methadone dose, and age on treatment outcome at an urban opioid treatment program. | Kritz S et al. | β | 2009 | β |
| Recreational cocaine polydrug use impairs cognitive flexibility but not working memory. | Colzato LS et al. | β | 2009 | β |
| Reward processing by the opioid system in the brain. | Le Merrer J et al. | β | 2009 | β |
| Sixty years of Pharmacological Reviews: has the role of review articles in biomedical sciences changed and, if so, how does this affect Pharmacological Reviews? | Brass EP et al. | β | 2009 | β |
| Addiction science and its genetics. | Ball D | β | 2008 | β |
| Anticipating clinical integration of pharmacogenetic treatment strategies for addiction: are primary care physicians ready? | Shields AE et al. | β | 2008 | β |
| A regulatory variation in OPRK1, the gene encoding the kappa-opioid receptor, is associated with alcohol dependence. | Edenberg HJ et al. | β | 2008 | β |
| Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment. | Crettol S et al. | β | 2008 | β |
| CNS genes implicated in relapse. | Kuntz-Melcavage KL et al. | β | 2008 | β |
| Convergence and divergence in the etiology of myelin impairment in psychiatric disorders and drug addiction. | Feng Y | β | 2008 | β |
| Crucial role of acetaldehyde in alcohol activation of the mesolimbic dopamine system. | Diana M et al. | β | 2008 | β |
| Current concepts about inhibition of platelet aggregation. | de Gaetano G et al. | β | 2008 | β |
| Genetic susceptibility to heroin addiction: a candidate gene association study. | Levran O et al. | β | 2008 | β |
| Genome-wide linkage analysis of heroin dependence in Han Chinese: results from Wave Two of a multi-stage study. | Glatt SJ et al. | β | 2008 | β |
| Genotype patterns that contribute to increased risk for or protection from developing heroin addiction. | Nielsen DA et al. | β | 2008 | β |
| Glutamate release in the nucleus accumbens core is necessary for heroin seeking. | LaLumiere RT et al. | β | 2008 | β |
| Human expression variation in the mu-opioid receptor is paralleled in rhesus macaque. | Vallender EJ et al. | β | 2008 | β |
| Investigating the molecular basis of major depressive disorder etiology: a functional convergent genetic approach. | Jabbi M et al. | β | 2008 | β |
| Isoquinoline alkaloids isolated from Corydalis yanhusuo and their binding affinities at the dopamine D1 receptor. | Ma ZZ et al. | β | 2008 | β |
| Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective. | Dumas EO et al. | β | 2008 | β |
| Reversal of cocaine-induced planarian behavior by parthenolide and related sesquiterpene lactones. | PagΓ‘n OR et al. | β | 2008 | β |
| Role of a functional human gene polymorphism in stress responsivity and addictions. | Kreek MJ | β | 2008 | β |
| Selective breeding for differential saccharin intake as an animal model of drug abuse. | Carroll ME et al. | β | 2008 | β |
| Selective breeding for intravenous drug self-administration in rats: a pilot study. | He S et al. | β | 2008 | β |
| Subjective, psychomotor, and physiological effects profile of hydrocodone/acetaminophen and oxycodone/acetaminophen combination products. | Zacny JP et al. | β | 2008 | β |
| The neurobiology and genetics of impulse control disorders: relationships to drug addictions. | Brewer JA et al. | β | 2008 | β |
| The value of CYP2D6 and OPRM1 pharmacogenetic testing for opioid therapy. | Reynolds KK et al. | β | 2008 | β |
| Acetaldehyde mediates alcohol activation of the mesolimbic dopamine system. | Melis M et al. | β | 2007 | β |
| Biotechnology and the treatment of addictive disorders: new opportunities. | Elkashef A et al. | β | 2007 | β |
| Buprenorphine maintenance: a new treatment for opioid dependence. | Collins GB et al. | β | 2007 | β |
| Case report: quantification of methadone-induced respiratory depression using toxicokinetic/toxicodynamic relationships. | MΓ©garbane B et al. | β | 2007 | β |
| Comparative analysis of mu-opioid receptor expression in immune and neuronal cells. | BΓΆrner C et al. | β | 2007 | β |
| Dopamine transporter gene (DAT1) associated with appetite suppression to methylphenidate in a case-control study of binge eating disorder. | Davis C et al. | β | 2007 | β |
| Epigenetic regulation in psychiatric disorders. | Tsankova N et al. | β | 2007 | β |
| Genetics of dopamine and its contribution to cocaine addiction. | Haile CN et al. | β | 2007 | β |
| Genomewide suggestive linkage of opioid dependence to chromosome 14q. | Lachman HM et al. | β | 2007 | β |
| Homovanillic acid (HVA) plasma levels inversely correlate with attention deficit-hyperactivity and childhood neglect measures in addicted patients. | Gerra G et al. | β | 2007 | β |
| Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction. | Gerra G et al. | β | 2007 | β |
| Knockout of the mu opioid receptor enhances the survival of adult-generated hippocampal granule cell neurons. | Harburg GC et al. | β | 2007 | β |
| Morphine effects on striatal transcriptome in mice. | Korostynski M et al. | β | 2007 | β |
| Neurobiology of HIV, psychiatric and substance abuse comorbidity research: workshop report. | Kopnisky KL et al. | β | 2007 | β |
| Opioids, dopamine, stress, and the addictions. | Kreek MJ | β | 2007 | β |
| Pharmacogenetic aspects of addictive behaviors. | Hejazi NS | β | 2007 | β |
| Pharmacotherapy of dual substance abuse and dependence. | Kenna GA et al. | β | 2007 | β |
| Stress, dysregulation of drug reward pathways, and the transition to drug dependence. | Koob G et al. | β | 2007 | β |
| The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor. | Kroslak T et al. | β | 2007 | β |
| Translational research in medication development for nicotine dependence. | Lerman C et al. | β | 2007 | β |
| A five-day gradual reduction regimen of chlormadinone reduces premenstrual anxiety and depression: a pilot study. | Contreras CM et al. | β | 2006 | β |
| Allelic expression of serotonin transporter (SERT) mRNA in human pons: lack of correlation with the polymorphism SERTLPR. | Lim JE et al. | β | 2006 | β |
| Association of the kappa-opioid system with alcohol dependence. | Xuei X et al. | β | 2006 | β |
| Biological research on drug abuse and addiction in Hispanics: current status and future directions. | Trujillo KA et al. | β | 2006 | β |
| Complaints of heroin-maintained patients: A survey of symptoms ascribed to diacetylmorphine. | DΓΌrsteler-MacFarland KM et al. | β | 2006 | β |
| Differential progesterone effects on defensive burying and forced swimming tests depending upon a gradual decrease or an abrupt suppression schedules. | Saavedra M et al. | β | 2006 | β |
| Distinctive profiles of gene expression in the human nucleus accumbens associated with cocaine and heroin abuse. | Albertson DN et al. | β | 2006 | β |
| Endogenous opiates and behavior: 2005. | Bodnar RJ et al. | β | 2006 | β |
| Genome-wide linkage analysis of heroin dependence in Han Chinese: results from wave one of a multi-stage study. | Glatt SJ et al. | β | 2006 | β |
| Large-scale mutagenesis and phenotypic screens for the nervous system and behavior in mice. | Vitaterna MH et al. | β | 2006 | β |
| Pharmacogenetics and the concept of individualized medicine. | Shastry BS | β | 2006 | β |
| Psychiatric comorbidity and progression in drug use in adult male twins: implications for the design of genetic association studies. | Todorov AA et al. | β | 2006 | β |
| Symbiotic relationship of pharmacogenetics and drugs of abuse. | Rutter JL | β | 2006 | β |
| The medical management of opioid dependence in HIV primary care settings. | Lum PJ et al. | β | 2006 | β |
| Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine. | Maurer HH et al. | β | 2006 | β |
| Biological clock: biological clocks may modulate drug addiction. | Yuferov V et al. | β | 2005 | β |
| Drugs for pain management in dentistry. | Hargreaves K et al. | β | 2005 | β |
| Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. | Kreek MJ et al. | β | 2005 | β |
| The contribution of genetics to addiction therapy approaches. | Edenberg HJ et al. | β | 2005 | β |